Caligan Partners LP — 13F holdings

Caligan Partners LP reported 28 holdings worth $2.13B in its 13F filing for Q2 2026, filed August 14, 2026.

Largest positions

1. LQDA LIQUIDIA CORPORATION — $647M (30.5%)
2. RVMD REVOLUTION MEDICINES INC — $415M (19.5%)
3. ABVX ABIVAX SA — $208M (9.8%)
4. PCVX VAXCYTE INC — $127M (6.0%)
5. EXEL EXELIXIS INC — $84.5M (4.0%)
6. TNGX TANGO THERAPEUTICS INC — $78.2M (3.7%)
7. AVTX AVALO THERAPEUTICS INC — $58.5M (2.8%)
8. XENE XENON PHARMACEUTICALS INC — $53.7M (2.5%)
9. ADMA ADMA BIOLOGICS INC — $50.4M (2.4%)
10. LBRX LB PHARMACEUTICALS INC — $46.7M (2.2%)